Search

Your search keyword '"Stern, Robert S."' showing total 717 results
Start Over Author "Stern, Robert S."
717 results on '"Stern, Robert S."'

10. Psoralen and Ultraviolet A light therapy for psoriasis

Author

Stern, Robert S.

Subjects
Psoriasis -- Care and treatment, Ultraviolet radiation -- Health aspects, Psoralens -- Health aspects
Abstract

The possible healing and relief that may be possible through the use of psoralen and ultraviolet A light in the management of psoriasis is presented.

Published
2007

12. Tretment of photoaging

Author

Stern, Robert S.

Subjects
Skin -- Aging, Skin -- Risk factors, Skin -- Case studies, Skin -- Care and treatment, Skin cancer -- Risk factors, Skin cancer -- Case studies, Skin cancer -- Care and treatment
Abstract

The risk factors for photoaging and skin cancer are observed through a case study. The clinical recommendations and strategies are mentioned.

Published
2004

13. Telaprevir-Related Dermatitis

Author

Roujeau, Jean-Claude, Mockenhaupt, Maja, Tahan, Steven R., Henshaw, Joshua, Martin, Emily C., Harding, Matt, van Baelen, Ben, Bengtsson, Leif, Singhal, Priya, Kauffman, Robert S., and Stern, Robert S.

Published
2013
Full Text
View/download PDF

14. Bullous pemphigoid therapy -- think globally, act locally

Author

Stern, Robert S.

Subjects
Bullous pemphigoid -- Drug therapy, Topical medication -- Evaluation, Corticosteroids -- Dosage and administration
Abstract

French researchers report that skin creams containing corticosteroids are more effective than oral corticosteroids in treating a skin disease called bullous pemphigoid but this treatment may not be available in the US. In France, patients with this condition can be hospitalized, but in the US they would have to be treated on an outpatient basis.

Published
2002

22. PUVA

Author

Lim, Jean L., primary and Stern, Robert S., additional

Published
2005
Full Text
View/download PDF

32. Psoriasis

Author

Stern, Robert S.

Subjects
Psoriasis -- Care and treatment
Published
1997

33. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA)

Author

Stern, Robert S., Nichols, Khanh T., and Vakeva, Liisa H.

Subjects
Melanoma -- Risk factors, Psoriasis -- Drug therapy, Photochemotherapy -- Adverse and side effects, Psoralens -- Adverse and side effects, Ultraviolet radiation -- Adverse and side effects
Abstract

People with psoriasis who receive long-term treatment with psoralen and ultraviolet A radiation may have an increased risk of melanoma. Psoralen and UV-A radiation (PUVA) is a very effective combination treatment for psoriasis. However, in a long-term study of 1,380 patients with psoriasis who began PUVA treatment in 1975-1976, researchers identified an increase in the incidence of melanoma after 1990. The incidence of melanoma 15 years after treatments began had increased 68% compared to the incidence in the first 5 years. Seven of the patients developed melanoma after 1991, a rate five times greater than normal.

Published
1997

48. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

Author

Roujeau, Jean-Claude, Kelly, Judith P., Naldi, Luigi, Rzany, Berthold, Stern, Robert S., Anderson, Theresa, Auquier, Ariane, Bastuji-Garin, Sylvie, Correia, Osvaldo, Locati, Francesco, Mockenhaupt, Maja, Paoletti, Catherine, Shapiro, Samuel, Shear, Neil, Schopf, Erwin, and Kaufman, David W.

Subjects
Stevens-Johnson syndrome -- Risk factors, Toxic epidermal necrolysis -- Risk factors, Antibacterial agents -- Adverse and side effects, Nonsteroidal anti-inflammatory drugs -- Adverse and side effects, Allopurinol -- Adverse and side effects, Corticosteroids -- Adverse and side effects
Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis are serious skin conditions often caused by reaction to drugs, with antibacterial sulfonamides associated most strongly. Researchers studied 245 patients who were diagnosed with the rare but potentially fatal diseases of Stevens-Johnson syndrome and toxic epidermal necrolysis in France, Germany, Italy, and Portugal. Each case patient was compared to three controls at the same hospital whose conditions were not related to drug use. The use of antibacterial sulfonamides, anticonvulsant agents, allopurinol, oxicam NSAIDS, chlormezanone, and corticosteroids were closely linked to the the development of these diseases, although the extra risk was not greater than five cases per million users a week. One or more of the drugs suspected of causing these diseases was used by 59% of case patients and 15% of controls.

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results